ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
The Investigational New Drug (IND) application proposed the clinical investigation of BLEX 404 as the primary active ingredient.
- The Investigational New Drug (IND) application proposed the clinical investigation of BLEX 404 as the primary active ingredient.
- The global cancer therapeutics market is expected to be worth around US$ 393.61 billion by 2032 from US$ 164 billion in 2022, growing at a CAGR of 9.20% from 2023 to 2032.
- [4] Straits Research reports that the global botanical drug market size was valued at $163 million in 2021 and is expected to be valued at $3.2 billion.
- The market is expected to grow at a CAGR of 39% during the forecast period (2022–2030).